Bain Capital Life Sciences Investors, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$675.9B
Holdings
24
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (24 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,719,110 | $219.4B | 32.46% | |
| 2 | NUVLNUVALENT INC | 1,447,267 | $102.6B | 15.19% | |
| 3 | PHVSPHARVARIS N V | 3,303,381 | $51.9B | 7.67% | |
| 4 | IRONDISC MEDICINE INC | 983,500 | $48.8B | 7.22% | |
| 5 | DNTHDIANTHUS THERAPEUTICS INC | 2,689,707 | $48.8B | 7.22% | |
| 6 | YB4PSAVARA INC | 17,600,621 | $48.8B | 7.21% | |
| 7 | SLDBSOLID BIOSCIENCES INC | 7,911,669 | $29.3B | 4.33% | |
| 8 | OLMAOLEMA PHARMACEUTICALS INC | 6,843,954 | $25.7B | 3.81% | |
| 9 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $22.3B | 3.29% | |
| 10 | CDTXCIDARA THERAPEUTICS INC | 703,080 | $15.1B | 2.24% | |
| 11 | UPBUPSTREAM BIO INC | 2,295,322 | $14.0B | 2.08% | |
| 12 | ANNXANNEXON INC | 5,249,069 | $10.1B | 1.50% | |
| 13 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $7.4B | 1.10% | |
| 14 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $6.5B | 0.96% | |
| 15 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $4.0B | 0.59% | |
| 16 | CABACABALETTA BIO INC | 2,760,888 | $3.8B | 0.57% | |
| 17 | TNGXTANGO THERAPEUTICS INC | 2,712,008 | $3.7B | 0.55% | |
| 18 | XLOXILIO THERAPEUTICS INC | 4,566,817 | $3.3B | 0.49% | |
| 19 | —MERSANA THERAPEUTICS INC | 8,663,673 | $3.0B | 0.44% | |
| 20 | IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $2.6B | 0.38% | |
| 21 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $1.8B | 0.26% | |
| 22 | IVVDINVIVYD INC | 1,799,595 | $1.1B | 0.16% | |
| 23 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,072,421 | $923.4M | 0.14% | |
| 24 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $899.0M | 0.13% |